obesity drug news today glp-1 today drugs Market Overview: GLP-1 Agonists and the Obesity Market Market Overview: GLP-1 Agonists and

J Obes Metab Syndr 2021;30:129.ArticlePubMedPMC 19

doi: 10.1016/j.bbrc.2016.05.086

3), generating the resultant metabolite, GLP-1(9-36)-NH 2

Direct head-to-head comparisons are not possible because the trials differed in duration, population and study design, but reporting outcomes side-by-side provides context

Countries with significant sales include the United States, Canada, Mexico, the United Kingdom, Germany, France, Italy, Spain, Denmark, Sweden, Norway, China, Japan, India, South Korea, Australia, Thailand, Brazil, Argentina, South Africa, the United Arab Emirates, Kuwait, and Saudi Arabia [66]

10.1111/dom.13172 67 WangY.ParlevlietE